Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort

Article Virology

Adverse events following immunization of COVID-19 (Covaxin) vaccine at a tertiary care center of India

Swayam Pragyan Parida et al.

Summary: The study aimed to assess adverse events following COVID-19 vaccine immunization and identify the predictors of these events. The study found that female sex, history of allergic reactions, presence of comorbidities, recent acute infection, and intake of chronic medications were major factors associated with adverse events. Precaution is needed when vaccinating individuals with these risk factors.

JOURNAL OF MEDICAL VIROLOGY (2022)

添加到收藏夹

Editorial Material Rheumatology

Systemic sclerosis and COVID-19 vaccines: a SPIN Cohort study

Jessica K. Gordon et al.

LANCET RHEUMATOLOGY (2022)

添加到收藏夹

Article Clinical Neurology

COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies

Albert Gil-Vila et al.

Summary: This study investigated the adverse events related to COVID-19 vaccination in patients with idiopathic inflammatory myopathies (IIMs) and other systemic autoimmune and inflammatory disorders (SAIDs) within 7 days postvaccination. The results showed higher rates of adverse events in IIM patients compared to healthy controls, particularly with regards to rashes. Overall, the benefit of preventing severe COVID-19 through vaccination likely outweighs the risk of vaccine-related adverse events.

MUSCLE & NERVE (2022)

添加到收藏夹

Article Rheumatology

Systemic sclerosis in the time of COVID-19

Anna-Maria Hoffmann-Vold et al.

Lancet Rheumatology (2022)

添加到收藏夹

Article Rheumatology

COVAD survey 2 long-term outcomes: unmet need and protocol

Zoha Zahid Fazal et al.

Summary: Vaccine hesitancy is a major obstacle to achieving herd immunity against COVID-19. Equitable vaccine uptake is crucial for managing the pandemic. Despite the absence of live-attenuated vaccines, short-term adverse events have raised concerns about potential long-term effects. The COVAD-2 survey aims to collect patient-reported data on the long-term safety and tolerability of COVID-19 vaccines in immune modulation.

RHEUMATOLOGY INTERNATIONAL (2022)

添加到收藏夹

Letter Rheumatology

Myositis as a manifestation of SARS-CoV-2

Maxime Beydon et al.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Review Rheumatology

Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis

Shintaro Akiyama et al.

Summary: Patients with autoimmune diseases have a higher risk of COVID-19, primarily due to glucocorticoid use. Monotherapy with b/tsDMARDs is associated with a lower risk of hospitalisation and death.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

Oxford-AstraZeneca COVID-19 vaccine efficacy

Maria Deloria Knoll et al.

LANCET (2021)

添加到收藏夹

Article Rheumatology

COVID-19 and Myositis: What We Know So Far

Ahmad Saud et al.

Summary: COVID-19-induced myositis can present in various forms, either due to direct virus invasion of muscle cells or induction of autoimmunity. The COVID-19 era has posed challenges for rheumatologists, disrupting chronic care for patients with established myositis and leading to the development of teleconsultation services.

CURRENT RHEUMATOLOGY REPORTS (2021)

添加到收藏夹

Article Rheumatology